Your browser doesn't support javascript.
loading
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Mantere, Tuomo; Tervasmäki, Anna; Nurmi, Anna; Rapakko, Katrin; Kauppila, Saila; Tang, Jiangbo; Schleutker, Johanna; Kallioniemi, Anne; Hartikainen, Jaana M; Mannermaa, Arto; Nieminen, Pentti; Hanhisalo, Riitta; Lehto, Sini; Suvanto, Maija; Grip, Mervi; Jukkola-Vuorinen, Arja; Tengström, Maria; Auvinen, Päivi; Kvist, Anders; Borg, Åke; Blomqvist, Carl; Aittomäki, Kristiina; Greenberg, Roger A; Winqvist, Robert; Nevanlinna, Heli; Pylkäs, Katri.
Affiliation
  • Mantere T; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, Northern Finland Laboratory Centre Nordlab Oulu, University of Oulu, Oulu, Finland.
  • Tervasmäki A; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, Northern Finland Laboratory Centre Nordlab Oulu, University of Oulu, Oulu, Finland.
  • Nurmi A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Rapakko K; Laboratory of Genetics, Northern Finland Laboratory Centre NordLab Oulu, Oulu, Finland.
  • Kauppila S; Cancer Genetic Unit, Service and Central Laboratory of Haematology, CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Tang J; Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Schleutker J; Departments of Cancer Biology and Pathology, Abramson Family Cancer Research Institute, Basser Research Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kallioniemi A; Medical Biochemistry and Genetics Institute of Biomedicine, University of Turku, Turku, Finland.
  • Hartikainen JM; Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
  • Mannermaa A; BioMediTech and FimLab Laboratories, University of Tampere, Tampere, Finland.
  • Nieminen P; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Hanhisalo R; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Lehto S; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Suvanto M; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Grip M; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Jukkola-Vuorinen A; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Tengström M; Medical Informatics and Statistics Research Group, University of Oulu, Oulu, Finland.
  • Auvinen P; Laboratory of Genetics, Northern Finland Laboratory Centre NordLab Oulu, Oulu, Finland.
  • Kvist A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Borg Å; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Blomqvist C; Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Aittomäki K; Department of Oncology, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Greenberg RA; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Winqvist R; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
  • Nevanlinna H; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Pylkäs K; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Sci Rep ; 7(1): 681, 2017 04 06.
Article in En | MEDLINE | ID: mdl-28386063

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Breast Neoplasms / Cell Cycle Proteins / Genetic Predisposition to Disease / Fanconi Anemia Complementation Group D2 Protein / Mutation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Sci Rep Year: 2017 Document type: Article Affiliation country: Finland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Breast Neoplasms / Cell Cycle Proteins / Genetic Predisposition to Disease / Fanconi Anemia Complementation Group D2 Protein / Mutation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Sci Rep Year: 2017 Document type: Article Affiliation country: Finland Country of publication: United kingdom